Alkermes Plc (ALKS)
46.53
-0.50
(-1.06%)
USD |
NASDAQ |
Nov 16, 16:00
46.53
0.00 (0.00%)
After-Hours: 20:00
Alkermes Price to Book Value : 4.193 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 4.193 |
| November 13, 2026 | 4.238 |
| November 12, 2026 | 4.233 |
| November 11, 2026 | 4.315 |
| November 10, 2026 | 4.187 |
| November 09, 2026 | 4.160 |
| November 06, 2026 | 4.136 |
| November 05, 2026 | 4.014 |
| November 04, 2026 | 4.135 |
| November 03, 2026 | 4.117 |
| November 02, 2026 | 4.045 |
| October 30, 2026 | 4.086 |
| October 29, 2026 | 4.088 |
| October 28, 2026 | 4.078 |
| October 27, 2026 | 3.994 |
| October 26, 2026 | 4.004 |
| October 23, 2026 | 3.932 |
| October 22, 2026 | 3.981 |
| October 21, 2026 | 3.918 |
| October 20, 2026 | 3.975 |
| October 19, 2026 | 3.872 |
| October 16, 2026 | 3.714 |
| October 15, 2026 | 3.613 |
| October 14, 2026 | 3.522 |
| October 13, 2026 | 3.580 |
| Date | Value |
|---|---|
| October 12, 2026 | 3.628 |
| October 09, 2026 | 3.659 |
| October 08, 2026 | 3.614 |
| October 07, 2026 | 3.735 |
| October 06, 2026 | 3.753 |
| October 05, 2026 | 3.853 |
| October 02, 2026 | 3.762 |
| October 01, 2026 | 3.653 |
| September 30, 2026 | 3.651 |
| September 29, 2026 | 3.780 |
| September 28, 2026 | 3.719 |
| September 25, 2026 | 3.784 |
| September 24, 2026 | 3.779 |
| September 23, 2026 | 3.903 |
| September 22, 2026 | 4.010 |
| September 21, 2026 | 4.093 |
| September 18, 2026 | 4.020 |
| September 17, 2026 | 4.327 |
| September 16, 2026 | 4.268 |
| September 15, 2026 | 4.264 |
| September 14, 2026 | 4.246 |
| September 11, 2026 | 4.259 |
| September 10, 2026 | 4.272 |
| September 09, 2026 | 4.206 |
| September 08, 2026 | 4.214 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amarin Corp. Plc | 0.5365 |
| Prothena Corp. Plc | 1.522 |
| Cue Biopharma, Inc. | 31.92 |
| ACADIA Pharmaceuticals, Inc. | 2.325 |
| Alnylam Pharmaceuticals, Inc. | 5.934 |
Price to Book Value Related Metrics
| PS Ratio | 4.548 |
| Price to Free Cash Flow | 35.08 |
| Price | 46.53 |
| Earnings Yield | -0.03% |
| Market Cap | 7.818B |
| Operating PE Ratio | 86.05 |
| Normalized PE Ratio | 460.69 |